Advanced pharmacology for prescribers 1st edition Luu Kayingo test bank

Advanced pharmacolo gy for prescribers 1st edition Luu K ayingo test bank Table of Contents Chapter 1: An Introduction to Evidence -Based Clinical Practice Guidelines ................................ .............. 3 Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics ................................ ................................ ..... 13 Chapter4: Pharmacogenetics and Pharmacogenomics ................................ ................................ ................ 25 Chapter 5: Pharmacology Across the Life Span ................................ ................................ ......................... 30 Chapter 6: Drug -Therapy Prescribing in Special Populations ................................ ................................ .... 36 Chapter 7: Drug Development and Approval ................................ ................................ ............................. 45 Chapter 8 -Chapter 10: Foundations of Prescription Writing Chap ter 9: ResponsibleControlled -Substance Prescribing Chapter 10: Antibiotic Stewardship ................................ ................................ .......................... 51 Chapter 11: Applied Calculations for Prescribing ................................ ................................ ...................... 58 Chapter 12 -: Promoting Adherence With Pharmacotherapy II: System -Specific and Patient -Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapter 14: Pharma cotherapy for Eye Conditions ................................ ................................ ................................ .......... 67 Chapter 15: Pharmacotherapy for Skin Conditions ................................ ................................ .................... 74 Chapter 16: Pharmacotherapy for Neurologic Conditions ................................ ................................ .......... 81 Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................ ................................ ... 94 Chapter 18: Pharmacotherapy for Respiratory Conditions ................................ ................................ ....... 106 Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNu tritional Support ................................ ................................ ................................ ................................ ...................... 117 Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................ ................................ ... 128 Chapter 21: Pharmacotherapy for Renal, Acid –Base, Fluid, and Electrolyte Disorders .......................... 133 Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions ............................... 146 Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................ ..................... 158 Chapter 24: Pharmacotherapy for Endocrine Disorders ................................ ................................ ........... 163 Chapter 25: Pharmacotherapy for Hematologic Disorders ................................ ................................ ....... 174 Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................ .... 190 Chapter 27: Pharmacotherapy Related to Women’s Health Conditions ................................ .................. 196 Chapter 28: Pharmacotherapy Related to Men’s Health Conditions ................................ ........................ 211 Chapter 29: Pharmacotherapy Related to Transgender Care ................................ ................................ .... 217 Chapter 30: Antimicrobial Pharmacotherapy ................................ ................................ ............................ 224 Chapter 31: Antiretroviral Pharmacotherapy ................................ ................................ ............................ 235 Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neurocognitive Conditions ................................ ................................ ................................ ........................ 247 Chapter 33: Pharmacotherapy for Pain Management ................................ ................................ ............... 257 Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance ................................ ........ 267 Chapter 35: Over -the-Counter Medications ................................ ................................ .............................. 283 Chapter 36: Pharmacotherapy for Obesity ................................ ................................ ................................ 291 Chapter 1: An Introduction to Evidence -Based Clinical Practice Guidelines MULTIPLE CHOICE • What is the primary purpose of the nursing assessment? A. Identifying underlying pathologic conditions B. Assisting the physician in identifying medical conditions C. Determining the patients mental status D. Exploring patient responses to health problems ANS: D A nursing assessment is done to identify the patients response to health problems. During the nursing assessment phase, a comprehensive information base is developed through a physical examination, nursing history, medication history, and professional obse rvation. Identifying underlying pathologic conditions and assisting the physician in identifying medical conditions is not part of the nursing process. Determining the patients mental status is one part of the nursing assessment, but it is not the primary purpose. DIF: Cognitive Level: Comprehension REF: dm 36 OBJ: 1 | 3 TOP: Nursing Process Step: Assessment MSC: NCLEX Client Needs Category: Health Promotion and Maintenance • What is the basis of the NANDA I taxonomy? A. Functional health patterns B. Human response patterns C. Basic human needs D. Pathophysiologic needs ANS: B The NANDA I taxonomy identifies human response patterns. Functional components of health patterns are limited to activity, fluid volume, nutrition, self care, and sensory perception. Basic human needs comprise less than merely health patterns. Pathophysiologic needs are not part of the scope of NANDA I. DIF: Cognitive Level: Knowledge REF: pp. 37 -38 OBJ: 5 TOP: Nursing Process Step: Diagnosis MSC: NCLEX Client Needs Category: Physiological Integrity • Which task is included in the assessment step of the nursing process? A. Establishing patient goals/outcomes B. Implementing the nursing care plan (NCP) C. Measuring goal/outcome achievement D. Collecting and communicating data ANS: D Data are collected and communicated in the assessment phase of the nursing process. Establishing goals is the function of planning. Implementing the NCP is the function of implementation. Measuring outcome achievement is the function of evaluation. DIF: C ognitive Level: Comprehension REF: dm 36 OBJ: 2 | 3 TOP: Nursing Process Step: Assessment MSC: NCLEX Client Needs Category: Health Promotion and Maintenance • Which statement regarding nursing diagnoses is accurate? a. Nursing diagnoses remain the same for as long as the disease is present. b. Nursing diagnoses are written to identify disease states. c. Nursing diagnoses describe patient problems that nurses treat. d. Nursing diagnoses identify causes related to illness. ANS: C Diagnostic statements identify problems a nurse is independently able to treat within the scope of professional practice. Nursing diagnoses vary with the changing condition of the patient. The response patterns are unique to the patient and are not disease specific. Nursing diagnoses describe the patients human response pattern. DIF: Cognitive Level: Comprehension